Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05899153 · ClinicalTrials.gov registry record · NA
Gait Adaptation and Biofeedback for Cerebral Palsy
A NA study of Cerebral Palsy, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05899153: Recruiting NA study of Cerebral Palsy, sponsored by University of Washington.
NCT05899153 is a NA study of Cerebral Palsy that is actively recruiting participants, run by University of Washington. The registered enrollment target is 36 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05899153, a NA study of Cerebral Palsy, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.
Primary Outcome
Average stance-phase magnitude of soleus muscle activity from electromyography recording measured during gait at 1-month follow-up.
Conditions Studied
Interventions
- DEVICE Biomotum Spark: Robotic ankle resistance
- DEVICE Audiovisual Biofeedback
- PROCEDURE Multilevel Orthopedic Surgery
Study Locations (1)
Minnesota
- Gillette Children's - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-11-28 |
| Est. Completion | 2029-01-01 |
| Phase | NA |
What NCT05899153 shows while recruiting
NCT05899153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 3 interventions - of which Biomotum Spark: Robotic ankle resistance is the first listed.
NCT05899153 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05899153 about?
NCT05899153 is a clinical study titled "Gait Adaptation and Biofeedback for Cerebral Palsy". This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability a...
What is the current status of trial NCT05899153?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-11-28. Estimated completion is 2029-01-01.
What conditions does trial NCT05899153 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT05899153?
The interventions under investigation include: Biomotum Spark: Robotic ankle resistance (DEVICE), Audiovisual Biofeedback (DEVICE), Multilevel Orthopedic Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05899153?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05899153 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05899153's enrollment target sits among peer trials
36 46th of 91 higher than 43 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI